Can lithium be used in the setting of clozapine commencement in patients with COVID‐19 associated neutropenia: A case report

Jin Quan Eugene Tan; Jessica L. Dawson; Tarun Bastiampillai

doi:10.1002/ccr3.8758

Clinical Case Reports (Apr 2024)

Can lithium be used in the setting of clozapine commencement in patients with COVID‐19 associated neutropenia: A case report

Jin Quan Eugene Tan,
Jessica L. Dawson,
Tarun Bastiampillai

Affiliations

Jin Quan Eugene Tan: SA Pharmacy, Flinders Medical Centre Southern Adelaide Local Health Network Adelaide South Australia Australia
Jessica L. Dawson: SA Pharmacy, Flinders Medical Centre Southern Adelaide Local Health Network Adelaide South Australia Australia
Tarun Bastiampillai: Discipline of Psychiatry, College of Medicine and Public Health Flinders University Adelaide South Australia Australia

DOI: https://doi.org/10.1002/ccr3.8758
Journal volume & issue: Vol. 12, no. 4
pp. n/a – n/a

Abstract

Read online

Key Clinical Message COVID‐19 infection may increase the likelihood of neutropenia in patients already on clozapine. In clozapine treated patients experiencing COVID‐19 associated neutropenia, adjunct therapy with lithium can be considered.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-0904

About the journal

Abstract

Keywords